# FDA 483 - Artegraft, Inc. - April 16, 2025

Source: https://www.keypedia.com/records/483/artegraft-inc/81d2d1fa-81af-44ce-bf7b-7db3dd1abcbf

> FDA 483 for Artegraft, Inc. on April 16, 2025. Product: device. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Artegraft, Inc.
- Inspection Date: 2025-04-16
- Product Type: device
- Office Name: New Jersey District Office
- Summary: LeMaitre Vascular, Inc. in North Brunswick, NJ, was inspected and received a Form FDA 483 with eight observations. The inspection revealed significant deficiencies across multiple quality system areas, including contamination control, environmental monitoring, equipment maintenance, process validation, bioburden monitoring, corrective and preventive actions, device history records, and employee training. These issues indicate a systemic lack of adherence to established procedures and regulatory requirements for medical device manufacturing.

## Related Documents

- [483 - 2025-04-16](https://www.keypedia.com/records/483/artegraft-inc/08edfad1-d279-47a2-b95f-6698d83de16e)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/matthew-w-kyle/0f297104-ae6c-4fc4-a240-c84e5e907803)
- [Frank J. Marciniak](https://www.keypedia.com/people/frank-j-marciniak/6995351a-6afc-4056-9692-d4aeb711dd92)
- [Monica L. Gutierrez](https://www.keypedia.com/people/monica-l-gutierrez/fe60f8c6-ad1b-4619-9903-ed7be6d3bf7d)

Company: https://www.keypedia.com/companies/artegraft-inc/ea31640f-5897-4972-8d68-16ea7ca1d8eb

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248